Anti-iRhom2 monoclonal antibody (SciRhom)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-iRhom2 monoclonal antibody (SciRhom)

Drug Alias NameRhomboid family member-2 inhibiting monoclonal antibodiesAnti-iRhom2 monoclonal antibodyRHBDF2 inhibiting mAbs

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionInactive rhomboid protein 2 inhibitors

TargetsInactive rhomboid protein 2

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSciRhom GmbH

China Registration ClassN/A

Active CompaniesSciRhom GmbH

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

ATC CodeN/A